引用文献


让基因编辑更简单
欢迎 : 退出
注册 | 登录
400-688-9033
当前位置: 首页 > 引用文献 >

引用文献

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 基因敲除服务 培养体系

引用文献

基因修饰细胞
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 培养体系
基因修饰微生物
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 培养体系
载体/病毒
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 培养体系
EZ-editor™产品
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 培养体系
CRISPR文库
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
作者: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
相关服务/产品: 培养体系
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
作者: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
相关服务/产品: 培养体系
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
作者: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
相关服务/产品: 基因敲除服务 培养体系
联系我们